CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-03 | Tessier-Lavigne Marc Director | Grant or award · Stock Option (right to buy) | +15,183 | 15,183 | ||
| 2020-06-03 | Tessier-Lavigne Marc Director | Grant or award · Restricted Stock Units | +3,253 | 3,253 | ||
| 2020-06-03 | FLATLEY JAY T Director | Grant or award · Stock Option (right to buy) | +15,183 | 15,183 | ||
| 2020-06-03 | FLATLEY JAY T Director | Grant or award · Restricted Stock Units | +3,253 | 3,253 | ||
| 2020-06-03 | Cook Jennifer E. Director | Grant or award · Stock Option (right to buy) | +15,183 | 15,183 | ||
| 2020-06-03 | Cook Jennifer E. Director | Grant or award · Restricted Stock Units | +3,253 | 3,253 | ||
| 2020-06-03 | Cole Douglas G. Director | Grant or award · Stock Option (right to buy) | +15,183 | 15,183 | ||
| 2020-06-03 | Cole Douglas G. Director | Grant or award · Restricted Stock Units | +3,253 | 3,253 | ||
| 2020-03-30 | Krognes Steve E. CFO and Treasurer | Sale | −1,428 | $19.48 | $28K | 1,006,488 |
| 2020-03-30 | Schuth Alexander O. COO and Secretary | Sale | −1,427 | $19.49 | $28K | 28,662 |
| 2020-03-30 | Ho Carole Chief Medical Officer | Sale | −1,428 | $19.48 | $28K | 2,822 |
| 2020-03-30 | Watts Ryan J. President and CEO | Sale | −4,807 | $19.48 | $94K | 22,013 |
| 2020-02-26 | BRATTON DOUGLAS K 10% owner | Sale | −3,894,764 | $20.25 | $78.9M | 15,567,736 |
| 2020-02-10 | Schuth Alexander O. COO and Secretary | Grant or award · Restricted Stock Units | +29,143 | 29,143 | ||
| 2020-02-10 | Schuth Alexander O. COO and Secretary | Grant or award · Stock Option (right to buy) | +136,000 | 136,000 | ||
| 2020-02-10 | Krognes Steve E. CFO and Treasurer | Grant or award · Restricted Stock Units | +29,143 | 29,143 | ||
| 2020-02-10 | Krognes Steve E. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +136,000 | 136,000 | ||
| 2020-02-10 | Watts Ryan J. President and CEO | Grant or award · Restricted Stock Units | +78,787 | 78,787 | ||
| 2020-02-10 | Watts Ryan J. President and CEO | Grant or award · Stock Option (right to buy) | +367,675 | 367,675 | ||
| 2020-02-10 | Ho Carole Chief Medical Officer | Grant or award · Restricted Stock Units | +29,874 | 29,874 |
Page 34 of 53 · 1,053 trades